Ads
related to: reusable insulin pen for novorapid- Embassador™ Companion App
Diabetes Lifestyle Management App
for People with Diabetes.
- Injection Technique Guide
Step-By-Step Guide
to Proper Insulin Injection.
- Embassador™ Companion App
Search results
Results from the WOW.Com Content Network
Insulin aspart can be used in an insulin pump and insulin pen for subcutaneous injection. Additionally, it can be used with an injection port such as the I-port. [25] Insulin aspart has a more rapid onset, and a shorter duration of activity than normal human insulin. [26] Insulin aspart can also be used with external insulin pumps. [13]
A major barrier to adoption in the United States was the increased up-front cost of insulin pens compared to traditional injections. [26] Pen adoption in the United States accelerated after studies showed that the higher up-front cost of insulin pens was offset by the increase in compliance, which decreased overall healthcare costs. [27]
A portable drug-delivery device, comprising an insulin container (prefilled for disposable pens, or refillable with cartridges); a dialing system to select the dose (in increments of 0.5 or 1 Unit); and a button which delivers the drug when pressed; disposable needles are attached prior to each use. To administrate insulin under the skin. [10]
Giving insulin with an insulin pen. Insulin pump in use. Insulin is used to treat a number of diseases including diabetes and its acute complications such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Use during pregnancy is relatively safe for the baby. [6]
Regular insulin, also known as neutral insulin and soluble insulin, is a type of short-acting medical insulin. [2] It is used to treat type 1 diabetes , type 2 diabetes , gestational diabetes , and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states . [ 5 ]
A November 2014 newspaper article, suggested that a recent medical research breakthrough at Harvard University (creating insulin-producing cells from embryonic stem cells) could potentially put Novo Nordisk out of business. Dr Alan Moses, the chief medical officer of Novo Nordisk, commented that the biology of diabetes is incredibly complex ...
Ads
related to: reusable insulin pen for novorapid